



| 货号 | HX861016 |
|---|---|
| 品牌 | abinScience |
| 描述 |
Research Grade Lerdelimumab (HX861016) is a human monoclonal antibody detecting Glioblastoma-derived T-cell suppressor factor in ELISA, Bioactivity: FACS, Functional assay, Research in vivo. Suitable for Human.
Highlights
|
| 种属反应性 | Human |
| 应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 同种型 | IgG4-lambda |
| 表达系统 | Mammalian cells |
| 种属 | Human |
| 靶标 | Glioblastoma-derived T-cell suppressor factor, TGF-beta-2, LAP, G-TSF, TGFB2, Cetermin, Transforming growth factor beta-2 proprotein |
| 内毒素水平 | < 10 EU/mg |
| 纯度 | >95% as determined by SDS-PAGE. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| Accession号 | P61812 |
| 状态 | Liquid |
| 保存溶液 | 0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 别名 | CAT-152, Trabio, 285985-06-0 |
| 背景 | Transforming growth factor beta-2 proprotein (Glioblastoma-derived T-cell suppressor factor,TGF-beta-2,LAP,G-TSF,TGFB2,Cetermin,Transforming growth factor beta-2 proprotein) is a ~47 kDa protein. Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-2 (TGF-beta-2) chains, which constitute the regulatory and active subunit of TGF-beta-2, respectively. |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype Control | Human IgG4 (S228P) Recombinant Isotype Control Antibody (13R4) (HP298207) |

Detects TGFB2 in indirect ELISAs.

SDS-PAGE for Research Grade Lerdelimumab





24小时产品查询

扫一扫关注我们

专属渠道经理